EnVVeno Medical Corporation (NASDAQ:NVNO)

BRIEF

published on 12/16/2024 at 14:55, 5 days ago

EnVVeno Medical Completes Key Phase in enVVe Study

EnVVeno Medical VenoValve Venous Disease FDA Submission GLP Study
PRESS RELEASE

published on 12/16/2024 at 14:50, 5 days ago

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
enVVeno Medical Corporation announces successful completion of all planned implants in GLP study for enVVe, maintaining timeline for IDE application submission by mid-2025

EnVVeno Medical Corporation CVI GLP Study IDE Application Venous Valve
BRIEF

published on 11/27/2024 at 14:35, 24 days 1 hour ago

EnVVeno Medical Unveils Recap Website from 2024 VEITH Symposium

Healthcare Innovation EnVVeno Medical Chronic Venous Insufficiency VenoValve® VEITH Symposium
PRESS RELEASE

published on 11/27/2024 at 14:30, 24 days 1 hour ago

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
enVVeno Medical Corporation launches recap website featuring interviews with patients and Primary Investigators from the VenoValve U.S. Pivotal Trial at the VEITH Symposium

Medical Device Chronic Venous Insufficiency EnVVeno Medical Corporation VEITH Symposium VenoValve U.S. Pivotal Trial
BRIEF

published on 11/20/2024 at 14:35, 1 month 1 day ago

EnVVeno Medical Unveils One-Year VenoValve Trial Results

Clinical Trial VenoValve Health Outcomes FDA Application CVI Treatment
PRESS RELEASE

published on 11/20/2024 at 14:30, 1 month 1 day ago

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
enVVeno Medical presents one-year data on VenoValve U.S. pivotal trial at VEITH Symposium supporting FDA pre-market authorization application. Study shows significant clinical benefits and safety profile

EnVVeno Medical VenoValve FDA Application Pivotal Trial VEITH Symposium
BRIEF

published on 11/19/2024 at 14:20, 1 month 2 days ago

EnVVeno Medical Seeks FDA Approval for VenoValve

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency PMA Application
PRESS RELEASE

published on 11/19/2024 at 14:15, 1 month 2 days ago

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno to present definitive one year data from PMA application at 51st VEITH Symposium. Company aims for FDA approval to market VenoValve in the US

FDA Approval VenoValve CVI PMA Application EnVVeno
BRIEF

published on 10/31/2024 at 13:40, 1 month 21 days ago

EnVVeno Medical's Q3 2024 Financials and Upcoming FDA Milestones

Financial Results FDA Approval Clinical Trials VenoValve EnVVe Progress
PRESS RELEASE

published on 10/31/2024 at 13:35, 1 month 21 days ago

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
enVVeno Medical Corporation reports progress towards FDA PMA approval for VenoValve and enVVe transcatheter-based valve replacement. Company ends quarter with $48.4M cash

Financial Results VenoValve Clinical Program FDA PMA Approval EnVVe Transcatheter Valve

1 2 ... 6

Published on 12/21/2024 at 01:30, 14 hours 9 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 9 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 34 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 39 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 9 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 47 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 53 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 28 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 42 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 38 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 21 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 39 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 44 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 1 hour ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 21 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News